NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Drug Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Apoptosis



Antimonial compounds may work by disrupting thiol homeostasis



March 24th, 2006

Antimonial compounds may work by disrupting thiol homeostasis.

According to recent research published in the journal Biochemical Pharmacology, "Trivalent antimonial compounds (Sb-III), originally used in the treatment of leishmaniasis, are now being proposed as a novel therapy for acute promyelocytic leukemia (APL). Here, we examine the effects of Sb-III and pentavalent antimonial drugs (Sb-v) on glutathione homeostasis, oxidative stress and apoptosis in the human leukemia monocyte cell line, THP-1. Although growth of THP-1 macrophages is unaffected by Sb', macrophages are extremely sensitive to Sb-III."

S. Wyllie and colleagues from the...


Source: Drug Week (2006-03-24)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login